Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Acquisition

1 Apr 2009 07:00

RNS Number : 8894P
First Derivatives PLC
01 April 2009
 



1 April 2009

First Derivatives plc

(AIM:FDP.L, IEX:GYQ.I)

Acquisition of Hologram

The Board of First Derivatives plc ("First Derivatives" or the "Company") announces that it has acquired Lepton Solutions Pty Limited (trading as "Hologram"), an Australian based technology company headquartered in Adelaide, for a total cash consideration of up to 2.2 million Australian dollars and 400,000 share options (the "Acquisition").  The Acquisition comprises an initial cash payment of 1.0 million Australian dollars.  In addition the four principals who own 96.4% of Hologram will receive 400,000 share options in First Derivatives (representing 2.9% of the Company's issued share capital). The share options vesting is subject to Hologram and its four principals achieving certain sales targets during the three years ending 31 March 2012. An additional deferred consideration to the four principals of Hologram, is payable, of up to a maximum of 1.2 million Australian dollars in cash.

Founded in 2004, with offices in Sydney and Adelaide, Hologram principals are leaders in the field of Risk Management and Stock Exchange Trading software. Risk management software developed by them was bought by Sungard and is in use in several hundred financial institutions and corporate treasuries worldwide. Their stock exchange trading system which is also currently in use in many stock exchanges around the world was sold to Computershare and is now owned by NASDAQ. In addition Hologram is the exclusive Australasian partner of Kx Systems in the financial services sector which complements First Derivatives exclusive partnership with Kx Systems in the financial services sector for North America, UK and Ireland.

The Acquisition grows First Derivatives existing presence in Asia Pacific and will help accelerate the Company's expansion by enhancing its global service offering. Hologram will also provide another channel to market for the Company's Delta product range for the Financial Services Sector in the areas of Algorithmic Trading, Market Data, Complex Event Processing (CEP) and Risk Management.

First Derivatives' CEO Brian Conlon said "The skills of Hologram's executive team complement those of First Derivatives extremely well and Hologram's product range will slot seamlessly into our Delta product suite. The Hologram principals have a track record of developing and marketing enterprise software in our domain and this expertise adds to our team of world class technology professionals. We continue to invest significant resources in research and development and the acquisition will help us expand our range of applications and adds corporate treasuries to our target customer base. The transaction is a coming together of two very like minded firms with a mutual emphasis on professionalism and a drive to produce market leading software."

Paul Phillips from Hologram said "We are excited about the opportunities that this transaction provides for Hologram. It gives us additional channels to market for our Treasury and Enterprise Risk Management systems and allows us to accelerate our plans by leveraging First Derivatives global presence and expertise in Kx technology. In addition we are looking forward to growing First Derivatives' sales and consulting presence in the Asia Pacific region and the acquisition will also enable us to expand our European operations in our Treasury Risk Consulting Business. 

Contact:

First Derivatives plc

Brian Conlon

 

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

 

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Diane Hodgson/Linda Hickey

 

Tel: +353 1 667 0420

Stakeholder Communications 

Carl Whyte 

Lisa Nugent

Tel: +44 (0)28 9033 9949

Tel: +44 (0) 20 7903 5148

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUUUUACUPBUAG
Date   Source Headline
11th Feb 20144:18 pmRNSDirector's Shareholding
10th Feb 20147:00 amRNSIssue of Equity
6th Feb 20147:00 amRNSOpening of Singapore Office
20th Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Dec 201311:08 amRNSTotal Voting Rights
20th Dec 20134:33 pmRNSIssue of Equity
5th Dec 20137:00 amRNSEnterprise Securities Market Notice
29th Nov 20134:00 pmRNSIssue of Equity
26th Nov 20137:00 amRNSASIC goes live with new surveillance system
5th Nov 20137:00 amRNSInterim Results
23rd Oct 20137:00 amRNSNotice of Results
30th Sep 20131:34 pmRNSTotal Voting Rights
18th Sep 20131:01 pmRNSCollaboration with NYSE Technologies
11th Sep 20137:00 amRNSEnterprise Securities Market Notice
10th Sep 20137:00 amRNSContract Win
5th Sep 20132:41 pmRNSIssue of Equity
30th Aug 20131:05 pmRNSTotal Voting Rights
21st Aug 20137:00 amRNSDelta Stream Selected by Communications Provider
14th Aug 20137:00 amRNSEnterprise Securities Market Notice
8th Aug 201312:53 pmRNSIssue of Equity
18th Jul 201312:55 pmRNSResult of AGM
9th Jul 20137:00 amRNSEnterprise Securities Market Notice
5th Jul 20134:11 pmRNSHolding(s) in Company
5th Jul 20134:10 pmRNSHolding(s) in Company
3rd Jul 20133:18 pmRNSIssue of Equity
3rd Jul 20137:00 amRNSEnterprise Securities Market Notice
28th Jun 20137:00 amRNSPlacing of 840,000 new ordinary shares
18th Jun 20137:00 amRNSFinal Results
5th Jun 20137:00 amRNSNotice of Results
9th May 20137:00 amRNSBoard restructuring
30th Apr 20138:00 amRNSTotal Voting Rights
26th Apr 20133:54 pmRNSEnterprise Securities Market Notice
23rd Apr 20137:00 amRNSEnterprise Securities Market Notice
19th Apr 20137:30 amRNSChange in Directors Shareholding
19th Apr 20137:30 amRNSGrant of Options
17th Apr 20133:10 pmRNSIssue of Equity
3rd Apr 20133:40 pmRNSDirector's Shareholding
2nd Apr 20137:00 amRNSPre-close period trading update
15th Mar 20137:00 amRNSSEF initiative & Compliance Officer appointment
28th Feb 20137:00 amRNSTotal Voting Rights
11th Feb 20137:00 amRNSEnterprise Securities Market Notice
6th Feb 20137:00 amRNSExercise of Options
4th Jan 20133:41 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSContract win
10th Dec 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSEnterprise Securities Market Notice
14th Nov 20127:00 amRNSDirector shareholding
13th Nov 20127:00 amRNSDirector shareholding
12th Nov 20123:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.